BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28467668)

  • 1. Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
    Kavishe RA; Koenderink JB; Alifrangis M
    FEBS J; 2017 Aug; 284(16):2579-2591. PubMed ID: 28467668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action.
    Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D
    ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on the mechanism of action of artemisinins.
    Golenser J; Waknine JH; Krugliak M; Hunt NH; Grau GE
    Int J Parasitol; 2006 Dec; 36(14):1427-41. PubMed ID: 17005183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species.
    Gopalakrishnan AM; Kumar N
    Antimicrob Agents Chemother; 2015 Jan; 59(1):317-25. PubMed ID: 25348537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.
    Wang J; Huang L; Li J; Fan Q; Long Y; Li Y; Zhou B
    PLoS One; 2010 Mar; 5(3):e9582. PubMed ID: 20221395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin resistance, some facts and opinions.
    Pantaleo A; Pau MC; Chien HD; Turrini F
    J Infect Dev Ctries; 2015 Jul; 9(6):597-9. PubMed ID: 26142668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinins in malaria treatment in the UK.
    Drug Ther Bull; 2010 Nov; 48(11):129-32. PubMed ID: 21057033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.
    Coertzen D; Reader J; van der Watt M; Nondaba SH; Gibhard L; Wiesner L; Smith P; D'Alessandro S; Taramelli D; Wong HN; du Preez JL; Wu RWK; Birkholtz LM; Haynes RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinins.
    Woodrow CJ; Haynes RK; Krishna S
    Postgrad Med J; 2005 Feb; 81(952):71-8. PubMed ID: 15701735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.
    Hastings I
    Trends Parasitol; 2011 Feb; 27(2):67-72. PubMed ID: 20971040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the pharmacology of antimalarial drug combination therapy.
    Hastings IM; Hodel EM; Kay K
    Sci Rep; 2016 Sep; 6():32762. PubMed ID: 27604175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of pediatric malaria in Africa: act at issue].
    Faucher JF; Missinou MA; Brasseur P
    Med Trop (Mars); 2006 Jun; 66(3):292-4. PubMed ID: 16924825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of artemisinin-based combination therapies.
    German PI; Aweeka FT
    Clin Pharmacokinet; 2008; 47(2):91-102. PubMed ID: 18193915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
    Haynes RK; Cheu KW; Chan HW; Wong HN; Li KY; Tang MM; Chen MJ; Guo ZF; Guo ZH; Sinniah K; Witte AB; Coghi P; Monti D
    ChemMedChem; 2012 Dec; 7(12):2204-26. PubMed ID: 23112085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria and artemisinin derivatives: an updated review.
    Ansari MT; Saify ZS; Sultana N; Ahmad I; Saeed-Ul-Hassan S; Tariq I; Khanum M
    Mini Rev Med Chem; 2013 Nov; 13(13):1879-902. PubMed ID: 24070206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the research on the targets of anti-malaria actions of artemisinin.
    Yang J; He Y; Li Y; Zhang X; Wong YK; Shen S; Zhong T; Zhang J; Liu Q; Wang J
    Pharmacol Ther; 2020 Dec; 216():107697. PubMed ID: 33035577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F; White NJ
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.